People: Nobel Biocare Holding AG (NOBN.S)

NOBN.S on Swiss Exchange

17.10CHF
11:30am EDT
Change (% chg)

CHF0.00 (+0.00%)
Prev Close
CHF17.10
Open
CHF17.10
Day's High
CHF17.15
Day's Low
CHF17.10
Volume
1,018
Avg. Vol
9,189
52-wk High
CHF18.45
52-wk Low
CHF11.95

Search Stocks

Summary

Name Age Since Current Position

Richard Laube

58 2011 Chairman of the Executive Committee, Chief Executive Officer

Philip Whitehead

2014 Chairman of the Board of Directors

Tullio Di Dio

2015 Chief Financial Officer

Frank Mengis

2013 Member of the Executive Committee, Executive Vice President Global Operations

Rolf Melker Nilsson

54 2013 Executive Vice President Head of Global Sales and Customer Development

Dietmar Bettio

46 2014 Member of the Executive Board, Executive Vice President

Hans Geiselhoeringer

46 2011 Executive Vice President Global Research Products & Development

Joerg von Manger-Koenig

54 2014 Senior Vice President Legal and Compliance, Member of the Executive Committee, Global Human Resources

Colin Davis

2014 Member of the Board of Directors

Jonathan Graham

2014 Member of the Board of Directors

Mischa Reis

2014 Member of the Board of Directors

Sueha Demokan

2004 Vice President Investor & Corporate Relations

Biographies

Name Description

Richard Laube

Mr. Richard T. Laube has been Chief Executive Officer (CEO) and Chairman of the Executive Committee at Nobel Biocare Holding AG since April 1, 2011. Prior to joining Nobel Biocare, Richard Laube held the position of CEO of Nestle Nutrition, Nestle SA and was member of the Nestle Executive Board between 2005 and 2010. He had joined Nestle as Deputy Executive Vice President, Corporate Business Development in 2005. From 1999 to 2005 he was President of Roche Consumer Health and from 2001rp 2005 also Member of the Roche Corporate Executive Committee. He also held the positions as Managing Director, Procter & Gamble, Brazi between 1996 and 1999, General Manager, Procter & Gamble Pharmaceuticals, Germany between 1992 and 1996 and various marketing and brand management positions with Procter & Gamble in Japan, the United States, and Switzerland from 1980 to 1992)/ He holds Master and Bachelor degrees in Organizational Development and Evaluation Research from the Boston University. Since 2008 he has been Independent Director of Logitech SA and Member of its Compensation Committee. Since 2010 he is Executive Advisor of Roark Capital Group.

Philip Whitehead

Mr. Philip Bernard Whitehead has been appointed Chairman of the Board of Directors of Nobel Biocare Holding Ltd effective December 15, 2014.

Tullio Di Dio

Mr. Tullio Di Dio has been appointed Chief Financial Officer of Nobel Biocare Holding Ltd effective February 1, 2015. He has 23 years of finance experience including assignments at United Technologies, Roche and during the past 12 years with Danaher. Most recently, Mr. Di Dio served as Vice President, Finance for Beckman Coulter EMEA. He played an important role in integrating Beckman Coulter into Danaher.

Frank Mengis

Mr. Frank Mengis was appointed Member of the Executive Committee, Executive Vice President Global Operations at Nobel Biocare Holding AG effective as of January 1, 2013. Mr. Mengis held senior management positions in Project Management and Development, Global Manufacturing, Operations and Quality Management at Straumann Institute. Prior to that, Mr. Mengis was Head of Pharma Capital Investment Projects at Karl Steiner, Switzerland, after having held various management positions at F. Hoffmann-La Roche, Switzerland, in areas including galenical engineering and pharmaceutical manufacturing. Mr. Mengis obtained a masters degree in Mechanical Engineering from the Universitaet Karlsruhe, and completed the Advanced Management Program at Harvard Business School.

Rolf Melker Nilsson

Mr. Rolf Melker Nilsson has been Executive Vice President Head of Global Sales and Customer Development at Nobel Biocare Holding AG. Previously, he was Member of the Executive Committee, Senior Vice President Global Sales and Customer Development at the company since August 12, 2011. He was President and General Manager North America, as well as Member of the Executive Committee at Nobel Biocare Holding AG from January 1, 2011. Mr. Nilsson has acted as Chief Operating Officer North America in the Company since January 2010. Mr. Nilsson has more than 18 years of experience in implant dentistry and with NobelProcera, which he gained through various management assignments at Nobel Biocare AG in Europe and North America from 1992 through 2005. Mr. Nilsson holds a master’s degree in law from Lund University in Sweden.

Dietmar Bettio

Mr. Dietmar Bettio has been appointed as Member of the Executive Board, Executive Vice President of Nobel Biocare Holding AG as of January 01, 2014. He joined Nobel Biocare in January of 2012.

Hans Geiselhoeringer

Mr. Hans Geiselhoeringer has been Executive Vice President Global Research Products & Development at Nobel Biocare Holding AG since November 30, 2011. He was previously Executive Vice President Global Marketing and Products and Member of the Executive Committee at the Company from 2010. He joined Nobel Biocare in 2008 to lead the Company’s NobelProcera business. Prior to joining Nobel Biocare, he had been expanding his Dental X laboratory business internationally. Mr. Geiselhoeringer founded Dental X GmbH in 1998, a dental laboratory chain specializing in implantology, anaplastology, functional and esthetic reconstructions, and imaging technologies. He was trained as a Certified Dental Technician (CDT) in Chicago, USA and received further dental training in New York, focusing on anaplastology and epithetics. He is a Technical business administrator from the IHK, Germany.

Joerg von Manger-Koenig

Mr. Joerg von Manger-Koenig has been Senior Vice President Legal and Compliance, Global Human Resources and Member of the Executive Committee at Nobel Biocare Holding AG since July 4, 2014. In this position he is responsible for Legal Affairs, Intellectual Property Rights, Quality, Environment and Regulatory Affairs in the Company. He acted as Group General Counsel and Secretary of the Board of Directors at the Company from 2007 to 2010. He joined the Company in 2007. Prior to that, he served as Executive Vice President Legal/Regulatory Affairs and Intellectual Property Rights at Berna Biotech AG between 2002 and 2006. Hr joined F. Hoffmann-La Roche in Basel in 1990, initially in corporate legal services (1995 -2002), then Head Global regulatory Affairs of the Vitamins and Fine Chemicals Division. Mr. von Manger-Koenig holds a degree in law from the Universitaet Bonn, Germany. He also studied law at the University of Geneva. He received practical legal education in Bonn, Cologne and Duesseldorf and with the Ciba-Geigy Pharma Division.

Colin Davis

Mr. Colin Davis has been appointed Member of the Board of Directors of Nobel Biocare Holding Ltd effective December 15, 2014.

Jonathan Graham

Mr. Jonathan P. Graham has been appointed Member of the Board of Directors of Nobel Biocare Holding Ltd effective December 15, 2014.

Mischa Reis

Mr. Mischa Reis has been appointed Member of the Board of Directors of Nobel Biocare Holding Ltd effective December 15, 2014.

Sueha Demokan

Search Stocks